将ApoE异形与Aβ结合,对它们的纤维化产生影响
Merlin Sardis1, Andra Noormägi1, Jüri Jarvet2,3
1Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn 19086, Estonia.
ACS omega
|February 23, 2026
概括
阿尔茨海默病 (AD) 涉及粉样ββ (Aβ) 的积累. 脂蛋白E (ApoE) 异型通过影响Aβ聚合来影响AD风险,观察到不同的结合亲和力和对Aβ纤维化的抑制作用.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,其特点是大脑中的粉样ββ (Aβ) 沉积.
- 脂蛋白E (ApoE) 异型,特别是ApoE4,是晚发性阿尔茨海默病 (LOAD) 的重要遗传风险因素.
- 在AD病变发生过程中,ApoE影响Aβ聚合和清除的确切机制尚未完全理解.
研究的目的:
- 研究不同Apolipoprotein E (ApoE) 异型和粉样β (Aβ) (Aβ1-40和Aβ1-42) 之间的结合相互作用.
- 用微尺度热泳 (MST) 描述ApoE异型对Aβ纤维化的影响.
- 确定ApoE异型体对Aβ1-42纤维细胞形成的相对抑制作用.
主要方法:
- 使用微尺度热泳 (MST) 来量化ApoE异型 (ApoE2,ApoE3,ApoE4) 和Aβ (Aβ1-40,Aβ1-42) 之间的结合亲和力 (Kd).
- 评估了ApoE异型体对Aβ1-42纤维化的抑制作用,在亚体胆量学度下.
- 计算了半最大抑制度 (IC50) 值,以比较不同ApoE异型体在抑制Aβ纤维化的功效.
主要成果:
- ApoE异型体与具有较低微分子亲和度的Aβ1-40和Aβ1-42结合.
- ApoE3对Aβ1-42表现出最强的结合 (Kd = 0.72 μM),而ApoE4表现出最弱的结合 (Kd = 2.80 μM).
- ApoE4对Aβ1-40的结合最强 (Kd = 1.59 μM),而ApoE2对Aβ1-40的结合最弱 (Kd = 5.29 μM).
- ApoE在亚基显微度度下抑制了Aβ1-42纤维化,这表明它在阻断纤维延长方面发挥了作用.
- 与ApoE3.3相比,ApoE4对Aβ1-42纤维化的抑制作用略强,ApoE2对Aβ1-42纤维化的抑制作用略弱.
结论:
- Apolipoprotein E 异型与粉样β 相互作用,因特定的异型和 Aβ 序列而有不同的亲和力.
- 阿波利波蛋白E对粉样β纤维化表现出抑制作用,可能是通过干扰纤维延长.
- 这些发现提供了关于ApoE对阿尔茨海默病病原发生的影响的分子机制的见解,特别是关于粉样β聚合和清除.
相关概念视频
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils
6.8K
6.8K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
615
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
615
Intracellular Signaling Affects Focal Adhesions
3.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.7K
Factors Affecting Protein-Drug Binding: Drug Interactions
660
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
660


